Evaluation of the protective effect of the intranasal vaccines adjuvanted with bacterium-like particles against intestinal infection
Ayato Tsujii(Gifu Pharmaceutical University), Tetsuo Koshizuka(Gifu Pharmaceutical University), Juri Koizumi(Gifu Pharmaceutical University), Sarana Kawashima(Gifu Pharmaceutical University), Keita Takahashi(Gifu Pharmaceutical University), Hiroki Fukushima(Gifu Pharmaceutical University), Haruki Harada(Gifu Pharmaceutical University), Naoki Inoue(Mukogawa Women's University), Hina Oikawa(Gifu Pharmaceutical University), Yuta Hayakawa(Gifu Pharmaceutical University)
Cited by 6
Related Papers
Human Herpesvirus 6B Genome Sequence: Coding Content and Comparison with Human Herpesvirus 6A
|Journal of Virology|1999|342
ICTV Virus Taxonomy Profile: Herpesviridae 2021
|Journal of General Virology|2021|255
Adoptive Transfer of MAGE-A4 T-cell Receptor Gene-Transduced Lymphocytes in Patients with Recurrent Esophageal Cancer
|Clinical Cancer Research|2015|180